Detalhe da pesquisa
1.
Structure-Based Identification of Potent Natural Product Chemotypes as Cannabinoid Receptor 1 Inverse Agonists.
Molecules
; 23(10)2018 Oct 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30322136
2.
Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition.
Nat Mater
; 13(6): 653-61, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24681647
3.
Flavonoids from Perovskia atriplicifolia and Their in Vitro Displacement of the Respective Radioligands for Human Opioid and Cannabinoid Receptors.
J Nat Prod
; 78(6): 1461-5, 2015 Jun 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-26035635
4.
Targeted injection of a biocomposite material alters macrophage and fibroblast phenotype and function following myocardial infarction: relation to left ventricular remodeling.
J Pharmacol Exp Ther
; 350(3): 701-9, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25022514
5.
Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.
Invest Ophthalmol Vis Sci
; 58(4): 2167-2179, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28399267
6.
In vitro opioid receptor affinity and in vivo behavioral studies of Nelumbo nucifera flower.
J Ethnopharmacol
; 174: 57-65, 2015 Nov 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-26260436
7.
Flavanones from Miconia prasina.
Phytochem Lett
; 7: 130-132, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24976876
8.
Local hydrogel release of recombinant TIMP-3 attenuates adverse left ventricular remodeling after experimental myocardial infarction.
Sci Transl Med
; 6(223): 223ra21, 2014 Feb 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-24523321